Skip to main content
. 2022 Aug 23;52(11):1247–1263. doi: 10.1111/cea.14212

TABLE 1.

Overview of pharmacological treatment options for the treatment of AR. 4 , 5 , 7 , 25 , 46 , 104 , 105

Treatment option Route of administration Including Effective against Less effective against Effect within Effect lasting Sufficient for Position in practice guidelines
Corticosteroids Intranasal

Beclomethasone dipropionate

Budesonide

Ciclesonide

Fluticasone furoate

Fluticasone propionate

Mometasone furoate

Flunisolide

Triamcinolone acetonide

Overall AR symptoms

Ocular symptoms

Nasal congestion

12 h 24 h Moderate‐to‐severe symptoms

ARIA: 1st choice for seasonal and persistent AR

AAO‐HNSF: For patients with a clinical diagnosis of AR whose symptoms affect their quality of life

Oral Predniso(lo)ne In a short period (5–7 days) for very severe nasal symptoms ARIA: A short course for moderate to severe nasal and/or ocular symptoms that are not controlled with other treatments
Antihistamines Oral (2nd generation)

Acrivastine

Bilastine

Cetirizine

Desloratadine

Ebastine

Fexofenadine

Levocetirizine

Loratadine

Mizolastine

Rupatadine

Rhinorrhoea

Sneezing

Nasal itching

Ocular symptoms

Nasal congestion 1–2 h 12–24 h Mild‐to‐moderate symptoms

ARIA: 2nd choice for seasonal and persistent AR

AAO‐HNSF: For patients with AR and primary complaints of sneezing and itching

Intranasal

Azelastine

Levocabastine

Nasal congestion

Nasal itching

Sneezing

Runny nose

1–2 h 12–24 h Mild‐to‐moderate symptoms

ARIA: 3rd choice for seasonal AR

AAO‐HNSF: For seasonal, perennial, or episodic AR

Ocular

Azelastine

Emedastine

Ketotifen

Levocabastine

Olopatadine

Allergic eye symptoms (conjunctivitis) 3–10 min, sometimes 30 min 4–8‐12 h Eye symptoms ARIA: For seasonal and persistent AR with conjunctivitis
Leucotriene antagonist Oral Montelukast Nasal symptoms (alone or in combination with antihistamines) 2 h Not as primary therapy used in patient with both AR and asthma

ARIA: 4th choice for seasonal AR

AAO‐HNSF: Not offered as primary therapy for patients with AR

Chromones Intranasal Cromolyn sodium

Nasal itching Rhinorrhoea

Sneezing

Nasal congestion Couple of days, sometimes weeks 3–4 h

Adjunct therapy

Mild symptoms

ARIA: 5th choice for seasonal and persistent AR
Ocular Cromolyn sodium Allergic eye symptoms (conjunctivitis) Couple of days 3–4 h Eye symptoms ARIA: For seasonal and persistent AR with conjunctivitis
Decongestants/imidazoline derivates Intranasal

Oxymetazoline

Tramazoline Xylometazoline

Nasal congestion 5 min 8–12 h

Adjunct therapy

Mild symptoms

ARIA: A very short course for seasonal and persistent AR and severe nasal obstruction with other treatment
Oral

Pseudoephedrine

Phenylephrine

Nasal congestion ARIA: Not suggested as therapy regularly
Anticholinergics Intranasal Ipratropium Rhinorrhoea Nasal symptoms 15 min 4–6 h

Adjunct therapy

Mild symptoms

ARIA: For persistent AR with rhinorrhoea

Note: AAO‐HNSF: American Academy of Otolaryngology—Head and Neck Surgery. Clinical Practice Guideline:Allergic Rhinitis. 104 ARIA: Allergic Rhinitis and its Impact on Asthma. Guidelines: 2010 Revision. 105